Your company is already operating in Germany and you would now like to export worldwide?
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
Innovative start-ups are booming in Germany's attractive life sciences sector.
As part of the Internationalization of Regions in Structural Transformation (ISW) program, Germany Trade & Invest is hosting an investor event for American Companies and Institutions about market opportunities in the healthcare industry.
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.
Germany's life sciences sector was the top medical device FDI destination in 2019 and 2020. Companies including Bayer and BioNTech are also expanding their footprint in the country.
The coronavirus pandemic has given German biotechnology companies a massive boom. What does the state of the industry look like two years after the start of the crisis?
Germany's biotech firms are booming, innovations are being made using 3D printing and digital apps are an export hit in the thriving life sciences sector.
